Literature DB >> 10964014

Pharmacological validation of an automated method of pain scoring in the formalin test in rats.

D Jourdan1, A Alloui, A Eschalier.   

Abstract

In 1997, we described a new automated method of scoring the pain behaviors in the formalin test. The algic behavior was automatically measured with the help of a video-analysis system. The time during which the animal grooms, licks, or bites itself was used as the parameter of pain. In the present study, we tested various analgesics to realize a pharmacological validation of the system. The effect of opiate analgesic (morphine, i.v.), nonsteroidal anti-inflammatory drugs (paracetamol, i.v., piroxicam, i.v., indomethacin, i.v.), antidepressant drugs (clomipramine, desipramine, nortryptyline, and paroxetine, i.p.), and serotonin (i.t.) were analyzed. A dose of 1.25 mg/kg of morphine induced a decrease in the scores of phases 1 and 2. Naloxone (0.25 mg/kg) reversed the effect of morphine (2.5 mg/kg). A 20-mg/kg dose of indomethacin induced a decrease in the second phase, and paracetamol induced a decrease in both phases (analgesic doses were 400 mg/kg and 200 mg/kg for first and second phases, respectively). Piroxicam had no effect on the pain scores. Clomipramine, desipramine, and paroxetine at a dose of 5 mg/kg induced a significant decrease in the second phase. Nortriptyline had no effect on the pain scores. A dose of 75 microg of serotonin induced a decrease in both phases 1 and 2. This study demonstrated that this system shows a good pharmacological sensitivity, although it is lower than that of manual assessment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10964014     DOI: 10.1016/s1056-8719(00)00067-8

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  1 in total

1.  Assessing complex movement behaviors in rodent models of neurological disorders.

Authors:  Kenneth E McCarson; Michelle K Winter; Dale R Abrahamson; Nancy E Berman; Peter G Smith
Journal:  Neurobiol Learn Mem       Date:  2018-02-21       Impact factor: 2.877

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.